Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
Link opens in a new tab
English
Deutsch
Search content at Technical University of Munich
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Adoptive immunotherapy with donor lymphocyte transfusions
Hans Jochem Kolb
, Ernst Holler
Ludwig-Maximilians-Universität München
Research output
:
Contribution to journal
›
Review article
›
peer-review
128
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adoptive immunotherapy with donor lymphocyte transfusions'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adoptive Immunotherapy
100%
Donor Lymphocytes
100%
Donor Lymphocyte Infusion
100%
Transfusion
100%
Marrow Transplantation
75%
Recurring
50%
Leukemia
50%
Graft-versus-host Disease (GvHD)
50%
Myelosuppression
50%
Chimerism
50%
Immune Response
25%
Lymphocytes
25%
Vaccination
25%
Cell number
25%
Breast Cancer
25%
Marrow
25%
Dendritic Cells
25%
Viral Disease
25%
T Cell Activation
25%
Transplantation Tolerance
25%
Human Patients
25%
Major Complications
25%
Solid Tumors
25%
Chronic Myeloid Leukemia
25%
Acute Lymphoblastic Leukemia
25%
Cancer Disease
25%
New Antigens
25%
Myeloma
25%
Acute Myeloid Leukemia
25%
Myelodysplastic Syndrome
25%
Allogeneic Bone Marrow Transplantation
25%
Graft-versus-leukemia Effect
25%
Cell Dose
25%
Immunocompetent Cells
25%
CD8-positive T Cells
25%
Chimeric Animals
25%
Leukemia Cancer
25%
Acute Lymphoblastic Lymphoma
25%
Increased Dose
25%
Medicine and Dentistry
Adoptive Immunotherapy
100%
Lymphocyte Transfusion
100%
Lymphocyte
100%
Leukemia
50%
T Cell
33%
Bone Marrow Suppression
33%
Graft Versus Host Reaction
33%
Cytokine
16%
Malignant Neoplasm
16%
Breast Cancer
16%
Virus Infection
16%
CD8 Antigen
16%
Chronic Myelogenous Leukemia
16%
Acute Lymphoblastic Leukemia
16%
Solid Malignant Neoplasm
16%
Myelodysplastic Syndrome
16%
Acute Myeloid Leukemia
16%
Allogenic Bone Marrow Transplantation
16%
Myeloma
16%
Immunoreactivity
16%
Graft Versus Leukemia Effect
16%
Lymphoblastic Lymphoma
16%
Transplantation Tolerance
16%
Dendritic Cell
16%